ProQR Therapeutics N.V. buy Chardan Capital
Start price
14.03.25
/
50%
€1.59
Target price
14.03.26
€3.69
Performance (%)
-0.25%
Price
13.03.26
€1.45
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for ProQR Therapeutics N.V. is nearly unchanged. This prediction currently runs until 14.03.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | -4.164% | -4.164% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.05
04.11.25
04.11.25
€3.48
04.11.26
04.11.26
-29.13%
13.03.26
13.03.26
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.80
08.08.25
08.08.25
€3.43
08.08.26
08.08.26
-11.57%
13.03.26
13.03.26
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.10
12.12.24
12.12.24
€3.81
12.12.25
12.12.25
-37.48%
13.12.25
13.12.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.86
10.05.24
10.05.24
€2.32
10.05.25
10.05.25
-20.11%
11.05.25
11.05.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.27
08.11.23
08.11.23
€1.87
08.11.24
08.11.24
170.93%
09.11.24
09.11.24